(NASDAQ: KMDA) Kamada's forecast annual revenue growth rate of 15.57% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Kamada's revenue in 2024 is $142,519,000.On average, 2 Wall Street analysts forecast KMDA's revenue for 2024 to be $9,094,410,920, with the lowest KMDA revenue forecast at $9,081,765,424, and the highest KMDA revenue forecast at $9,107,056,416. On average, 2 Wall Street analysts forecast KMDA's revenue for 2025 to be $11,211,669,334, with the lowest KMDA revenue forecast at $10,058,917,400, and the highest KMDA revenue forecast at $12,364,421,268.
In 2026, KMDA is forecast to generate $12,509,844,474 in revenue, with the lowest revenue forecast at $11,208,507,960 and the highest revenue forecast at $13,811,180,988.